Abbott to build nutrition manufacturing plant in China
The company’s senior executive Landgraf has recently presented a data to that extent at the China International Food Safety & Quality Conference 2012. The plant, which is expected
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
Multi-centre, randomized trial designed to compare C3BS-CQR-1 treatment with sham treatment is expected to enroll at least 240 patients suffering from chronic advanced symptomatic heart failure. The composite